Literature DB >> 26181425

An Infant With Medulloepithelioma Successfully Treated by High-dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation Without Radiotherapy.

Tomomi Hayase1, Akira Morimoto, Yuta Kawahara, Masaki Yagi, Nobuyuki Kanai, Sumito Nobusawa, Junko Hirato, Akira Gomi.   

Abstract

Medulloepithelioma of the central nervous system (CNS) is a rare primitive neuroectodermal tumor characterized by highly malignant behavior occurring in early childhood. Few cases have been reported and optimal management remains unknown. Here, we report a case of CNS medulloepithelioma successfully treated with high-dose chemotherapy (HDCTX) followed by autologous stem cell transplantation (auto-SCT) without radiotherapy. At the last follow-up, 3.0 years after onset, the patient was alive with no sign of relapse and normal development. To the best of our knowledge, this is the first reported case of long-term survival of CNS medulloepithelioma treated by HDCTX/auto-PBSCT without radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26181425     DOI: 10.1097/MPH.0000000000000381

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Medulloepithelioma with heterologous osteoid component: a case report and review of literature.

Authors:  Yanal Omari; Ahmad A Karkash; Razan A Mansour; Nisreen Amayiri; Maisa Swaidan; Maysa Al-Hussaini
Journal:  Childs Nerv Syst       Date:  2019-01-08       Impact factor: 1.475

2.  Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene.

Authors:  Shi-Min Xu; Ting Liang
Journal:  Exp Ther Med       Date:  2015-11-24       Impact factor: 2.447

3.  A surgical case of pediatric spinal medulloepithelioma.

Authors:  Kazuki Nakamura; Ken-Ichiro Matsuda; Takanobu Kabasawa; Toru Meguro; Akira Kurose; Yukihiko Sonoda
Journal:  Childs Nerv Syst       Date:  2021-07-26       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.